Skip to main content

Table 1 The chi-square test of the relation between risk score and clinical features in TCGA cohort

From: Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma

Clinical features

TCGA, n = 365

High risk

Low risk

P

Survival status

  

< 0.001

 Survived

45

194

 

 Died

51

75

 

 Age

  

0.89

 ≥ 60 years

52

148

 

 < 60 years

44

121

 

Sex

  

0.23

 Male

60

186

 

 Female

36

83

 

Histological grade

  

0.06

 G1–2

53

177

 

 G3–4

42

88

 

 Gx

1

4

 

Stage

  

< 0.001

 I–II

55

199

 

 III–IV

35

52

 

x

6

18

 

T classification

  

< 0.01

 T1–2

61

210

 

 T3–4

35

56

 

 Tx

0

3

 

N classification

  

0.30

 N0

66

182

 

 N1

2

2

 

 Nx

28

85

 

M classification

  

0.12

 M0

69

194

 

 M1

2

1

 

 Mx

25

74

 

Cirrhosis status

  

0.74

 No cirrhosis

16

61

 

 Cirrhosis

30

102

 

 Unknown

50

106

 

Recurrence status

  

0.38

 No recurrence

35

117

 

 Recurrence

43

114

 

 Unknown

18

38

 

Hepatitis status

  

0.81

 Hepatitis B

21

67

 

 Hepatitis C

11

32

 

 No hepatitis

64

170

 
  1. The cases with “Gx,” “Tx,” “Nx,” “Mx,” stage “x,” cirrhosis status “unknown,” and recurrence status “unknown” were excluded from the chi-square test
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us